Evidence map›Paper›PMID 37564740›Full record

ArticleOpen forum infectious diseases2023

Successful Treatment of

Joseph Pechacek, Taura Webb, Elise M N Ferré, Monica M Schmitt, Thomas DiMaggio, Dale Kobrin, Suraj Rajasimhan, Ben Colton, Russell E Lewis, David Andes and 7 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Joseph PechacekFungal Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Taura WebbFungal Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Elise M N FerréFungal Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Monica M SchmittFungal Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Thomas DiMaggioFungal Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Dale KobrinLupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland, USA.
Suraj RajasimhanPharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Ben ColtonPharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Russell E LewisDipartimento di Medicine Molecolare, University of Padua, Padua, Italy.ORCID https://orcid.org/0000-0002-2002-4339
David AndesDivision of Infectious Diseases, Department of Medical Microbiology and Immunology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Alejandro HerreraVirtua Infectious Disease, Virtua Voorhees, Virtua Medical Group, Vorhees, New Jersey, USA.
Dima HammoudRadiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Seyedmojtaba SeyedmousaviMicrobiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Sarfaraz HasniLupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, Maryland, USA.
Jonathan BolañosKidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Behdad AfzaliKidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Michail S LionakisFungal Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0003-4994-9500
National Institutes of Health · USNational Institutes of Health Clinical Center · USUniversity of Padua · ITUniversity of Wisconsin–Madison · US

Funding

Unravelling immunoregulatory circuits of tissue inflammationZIADK075149 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI AFZALI, BEHDAD · 2019 to 2025
$19.3M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cyclophosphamidedrug–drug interactionslupus nephritisPaecilomycesposaconazole

Identifiers

PMID37564740
PMCPMC10411043
OpenAlexW4385492512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.